Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Free Report) have received an average rating of “Hold” from the fifteen research firms that are covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a sell rating, five have issued a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $29.8462.
Several equities analysts have weighed in on the company. Cantor Fitzgerald restated a “neutral” rating on shares of Acadia Healthcare in a research note on Wednesday, July 29th. Guggenheim upped their target price on shares of Acadia Healthcare from $38.00 to $39.00 and gave the stock a “buy” rating in a research note on Thursday, July 30th. KeyCorp raised their price target on shares of Acadia Healthcare from $30.00 to $40.00 and gave the company an “overweight” rating in a research report on Tuesday, July 14th. Jefferies Financial Group upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and boosted their price target for the stock from $24.50 to $30.00 in a report on Wednesday, June 3rd. Finally, TD Cowen upped their price objective on shares of Acadia Healthcare from $30.00 to $36.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th.
Check Out Our Latest Stock Analysis on ACHC
Hedge Funds Weigh In On Acadia Healthcare
Acadia Healthcare Price Performance
ACHC stock opened at $27.38 on Friday. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.57 and a current ratio of 1.57. The business has a 50-day simple moving average of $30.31 and a two-hundred day simple moving average of $27.10. The company has a market capitalization of $2.55 billion, a P/E ratio of -2.20, a price-to-earnings-growth ratio of 9.02 and a beta of 0.62. Acadia Healthcare has a 52-week low of $11.43 and a 52-week high of $35.83.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last posted its earnings results on Tuesday, July 28th. The company reported $0.38 earnings per share for the quarter, beating analysts’ consensus estimates of $0.35 by $0.03. The company had revenue of $865.84 million for the quarter, compared to analyst estimates of $844.19 million. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.The company’s revenue for the quarter was down .4% on a year-over-year basis. During the same quarter last year, the company earned $0.83 earnings per share. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. Research analysts expect that Acadia Healthcare will post 1.55 EPS for the current fiscal year.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services. The company operates facilities that offer treatment for mental health conditions, substance use disorders and other behavioral health needs. Its services are designed for children, adolescents and adults and may include inpatient psychiatric care, residential treatment, outpatient programs and specialized care.
Acadia’s facilities provide a range of treatment programs, including psychiatric hospitals, addiction treatment centers, eating disorder programs and other specialty behavioral healthcare services.
Further Reading
- Five stocks we like better than Acadia Healthcare
- Running on Empty: 3 Energy Plays for Europe’s Deep Freeze
- 3 Healthcare Stocks for 3 Stages of Life
- Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid
- MarketBeat’s Most Downgraded Stocks in Q3: 2 Look Cheap, 1 Looks Risky
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
